Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Inflammatory Response: early-phase trial registry

5 of 17 indexed Inflammatory Response trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,004 of 28,707 conditions by registered trial count.

17 US clinical trials · 5 currently recruiting · #1,004 of 28,707 conditions by registered trial count

Inflammatory Response: 17 US clinical trials tracked, 5 recruiting.

Inflammatory Response is the subject of 17 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Utah State University, running 2 of these trials.

Enrollment posture brief

Registry condition inflammatory-response

OPEN 5 | RECR 29% | LATE 1 | EARLY 3 | RANK #1004 | SPON 2

Nearest open-share peer: Addiction (29% recruiting · 17 trials)

Acute Myeloid Leukemia, in R70.6%Abdominal Aortic Aneurysm52.9%Inflammatory Response (this)29%Acute Lymphoblastic Leukemia23.5%Actinic Keratosis11.8%
Open-enrollment share among volume-matched conditions near Inflammatory Response

Inflammatory Response lists 5 open slots (29% of 17 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Inflammatory Response on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Inflammatory Response is recruiting below its size-band peers.

    5 of 17 indexed trials (29.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Inflammatory Response trials is spread across many organizations.

    Utah State University accounts for 2 of 17 trials (11.8%). 16 distinct sponsors appear on at least one study for this condition label.

  3. Most Inflammatory Response trials plan to enrol fewer than 100 people.

    Median target enrolment is 66 among the 17 trials that report a genuine target (sentinel values excluded). 11 of those (64.7%) plan for fewer than 100 participants.

  4. Inflammatory Response research is mostly interventional.

    17 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 31

Open and recent trials

17 total, page 1 of 1

RECRUITING NA 480 participants

Social Experiences and Demographic Factors in the Regulation of Immune Cells

Morgan State University

NCT06519487

RECRUITING NA 120 participants

Daoist Zhanzhuang and Human Flourishing

University of North Carolina, Charlotte

NCT06573034

RECRUITING NA 68 participants

Menthol, Inflammation, and Nicotine Transition Study

Rosalind Franklin University of Medicine and Science

NCT06232447

RECRUITING NA 40 participants

Association Between Body Composition and Pain in Spinal Cord Injury

University of Miami

NCT05459207

RECRUITING NA 30 participants

Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise

University of Southern California

NCT05934708

ACTIVE NOT RECRUITING NA 144 participants

Pistachio Consumption on Inflammatory Markers and Lean Body Mass

Virginia Polytechnic Institute and State University

NCT06342024

ACTIVE NOT RECRUITING NA 103 participants

Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human

Clinical Nutrition Research Center, Illinois Institute of Technology

NCT04267705

ACTIVE NOT RECRUITING Early Phase 1 66 participants

Sleep and Inflammatory Resolution Pathway

Beth Israel Deaconess Medical Center

NCT03377543

ACTIVE NOT RECRUITING NA 46 participants

Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles

University of Connecticut

NCT06086795

ACTIVE NOT RECRUITING NA 36 participants

Beef and Plant Burger Metabolomics Study

Utah State University

NCT05690061

ACTIVE NOT RECRUITING NA 34 participants

The Effects of Agro-ecological Farming Systems on Human Health

Utah State University

NCT05575258

COMPLETED Phase 3 1,263 participants

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

Kevin Hill

NCT03229538

COMPLETED Early Phase 1 249 participants

Persistent Readiness Through Early Prediction Immunization Study

Texas A&M University

NCT05346302

COMPLETED NA 69 participants

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

Formula30A

NCT05743985

COMPLETED Phase 1 45 participants

Inhibition of Sterile Inflammation by Digoxin

Yale University

NCT03559868

COMPLETED NA 29 participants

Cranberry Ingestion and Cycling Related Immunity and Inflammation

Appalachian State University

NCT05407701

COMPLETED NA 25 participants

The Effect of Chiropractic Plus Nutritional Supplement in Patients With Chronic Pain and Inflammation.

Standard Process

NCT05743855

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 3 1

Named interventions

Most-linked intervention names on Inflammatory Response records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Other
2 trials
Cranberry Juice Dietary supplement
1 trials
Typhim VI Drug
1 trials
Pneumovax 23 Drug
1 trials
Cannabigerol Other
1 trials
Nutritional Supplement Dietary supplement
1 trials
Isotonic saline Drug
1 trials
Pistachio group Other
1 trials

US sites by state

Facility locations filed on Inflammatory Response trials. A trial with sites in several states counts in each.

Texas 4 trials
North Carolina 4 trials
Illinois 3 trials
Utah 2 trials
Maryland 2 trials
Florida 2 trials
Connecticut 2 trials
California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Inflammatory Response page

17 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Inflammatory Response condition card totals 17 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.